Works matching Olanzapine
Results: 5000
Olanzapine optimal dose: Results of an open-label multicenter study in schizophrenic patients.
- Published in:
- Psychiatry & Clinical Neurosciences, 2000, v. 54, n. 4, p. 467, doi. 10.1046/j.1440-1819.2000.00738.x
- By:
- Publication type:
- Article
Olanzapine alleviates oxidative stress in the liver of socially isolated rats.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2017, v. 95, n. 6, p. 634, doi. 10.1139/cjpp-2016-0598
- By:
- Publication type:
- Article
THE EFFICACY OF OLANZAPINE IN PATIENTS WITH SCHIZOFRENIA.
- Published in:
- Medical Journal / Medicinski Žurnal, 2011, v. 17, n. 2, p. 153
- By:
- Publication type:
- Article
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Augmentation of olanzapine in treatment-resistant schizophrenia.
- Published in:
- Journal of Pediatric Psychology, 2005, v. 30, n. 8, p. 409
- By:
- Publication type:
- Article
Olanzapine use for the treatment of adolescents with anorexia nervosa – reflecting on research and clinical practice.
- Published in:
- Journal of the Canadian Academy of Child & Adolescent Psychiatry, 2024, v. 33, n. 3, p. 164
- By:
- Publication type:
- Article
Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial.
- Published in:
- Journal of the Canadian Academy of Child & Adolescent Psychiatry, 2018, v. 27, n. 3, p. 197
- By:
- Publication type:
- Article
Olanzapinle ılişkili Periferik Ödem: Olgu Sunumu.
- Published in:
- 2008
- By:
- Publication type:
- Case Study
Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients.
- Published in:
- Al-Mustansiriyah Journal for Pharmaceutical Sciences, 2023, v. 23, n. 2, p. 117, doi. 10.32947/ajps.v23i2.1013
- By:
- Publication type:
- Article
Restless legs syndrome in a bipolar disorder patient treated with olanzapine: is there an association?
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Olanzapine-Induced Hyperprolactinemia: Two Case Reports.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00846
- By:
- Publication type:
- Article
Olanzapine. Pharmacokinetic and pharmacodynamic profile.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months.
- Published in:
- Journal of Psychopharmacology, 2010, v. 24, n. 1, p. 121, doi. 10.1177/0269881108096504
- By:
- Publication type:
- Article
Antipsychotics inhibit glucose transport: Determination of olanzapine binding site in Staphylococcus epidermidis glucose/H+ symporter.
- Published in:
- FEBS Open Bio, 2015, v. 5, p. 335, doi. 10.1016/j.fob.2015.04.006
- By:
- Publication type:
- Article
Olanzapine Bağlı Obsesif-Kompülsif Semptomlar Oluşan Bir Capgras Sendromu Olgusu.
- Published in:
- Dicle Medical Journal / Dicle Tip Dergisi, 2019, v. 46, n. 2, p. 379, doi. 10.5798/dicletip.539908
- By:
- Publication type:
- Article
Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine.
- Published in:
- Journal of Neural Transmission, 2003, v. 110, n. 1, p. 111, doi. 10.1007/s00702-002-0792-6
- By:
- Publication type:
- Article
Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2007, v. 22, n. 1, p. 11, doi. 10.1002/hup.819
- By:
- Publication type:
- Article
Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine-induced weight gain.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 6, p. 545, doi. 10.1111/j.1463-1326.2009.01185.x
- By:
- Publication type:
- Article
Intramuscular olanzapine: a review of its use in the management of acute agitation.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Účinnost/bezpečnost olanzapinu v tabletách dispergovatelných v ústech.
- Published in:
- Psychiatrie Pro Praxi, 2022, v. 23, n. 5, p. 187
- By:
- Publication type:
- Article
Síndrome post-inyección por olanzapina de liberación retardada: Breve revisión a propósito de un caso.
- Published in:
- Actas Espanolas de Psiquiatria, 2013, v. 41, n. 1, p. 60
- By:
- Publication type:
- Article
Síndrome post-inyección por olanzapina de liberación retardada: Breve revisión a propósito de un caso.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Niveles de glucosa en modelo de rata diabética bajo el uso de olanzapina.
- Published in:
- Revista Neurologia, Neurocirugia y Psiquiatria, 2011, v. 44, n. 2, p. 57
- By:
- Publication type:
- Article
Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine‐Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 459, doi. 10.1002/cpdd.601
- By:
- Publication type:
- Article
An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco.
- Published in:
- Annals of General Psychiatry, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12991-024-00516-y
- By:
- Publication type:
- Article
Olanzapine Y ol CII Tardive Discontinuing, Clozapine Ile Treedaisy.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S262
- By:
- Publication type:
- Article
Şizofreni Hastalarında Olanzapine Yanıtla Sinaptozomla İlişkili Protein (SNAP-25) Gen Polimorfizmi İlişkisi.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S145
- By:
- Publication type:
- Article
Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 1083, doi. 10.2147/NDT.S158339
- By:
- Publication type:
- Article
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.
- Published in:
- Neuropsychiatric Disease & Treatment, 2013, v. 9, p. 1737, doi. 10.2147/NDT.S50635
- By:
- Publication type:
- Article
Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.
- Published in:
- BMC Psychiatry, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12888-015-0450-9
- By:
- Publication type:
- Article
Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.
- Published in:
- BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-224
- By:
- Publication type:
- Article
Acute Bipolar Depression: A Review of the Use of Olanzapine/Fluoxetine.
- Published in:
- Clinical Medicine Insights: Therapeutics, 2010, n. 2, p. 825, doi. 10.4137/CMT.S1945
- By:
- Publication type:
- Article
Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia.
- Published in:
- Psychiatry & Clinical Neurosciences, 2004, v. 58, n. 4, p. 364, doi. 10.1111/j.1440-1819.2004.01269.x
- By:
- Publication type:
- Article
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1049, doi. 10.1177/10600280211070330
- By:
- Publication type:
- Article
奥氮平联合舍曲林对于奥氮平血药浓度的影响研究.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2023, v. 23, n. 3, p. 264, doi. 10.14009/j.issn.1672-2124.2023.03.002
- By:
- Publication type:
- Article
Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.930457
- By:
- Publication type:
- Article
Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: Results of the Japan multicenter, double-blind olanzapine trial.
- Published in:
- Psychiatry & Clinical Neurosciences, 2001, v. 55, n. 4, p. 403, doi. 10.1046/j.1440-1819.2001.00882.x
- By:
- Publication type:
- Article
Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia relapse in Germany.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 2, p. 85, doi. 10.1007/s10198-002-0161-2
- By:
- Publication type:
- Article
Effects of olanzapine during cognitive and emotional processing in schizophrenia: A review of functional magnetic resonance imaging findings.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 3, p. N.PAG, doi. 10.1002/hup.2693
- By:
- Publication type:
- Article
The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic-naive first-episode schizophrenic patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 6, p. 419, doi. 10.1002/hup.2558
- By:
- Publication type:
- Article
Post authorization safety study comparing quetiapine to risperidone and olanzapine.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 4, p. 304, doi. 10.1002/hup.2539
- By:
- Publication type:
- Article
SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 3, p. 252, doi. 10.1002/hup.2532
- By:
- Publication type:
- Article
Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 2, p. 83, doi. 10.1002/hup.2515
- By:
- Publication type:
- Article
Olanzapine as the ideal 'trip terminator'? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 4, p. 249, doi. 10.1002/hup.2431
- By:
- Publication type:
- Article
A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 1, p. 83, doi. 10.1002/hup.2376
- By:
- Publication type:
- Article
Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 3, p. 205, doi. 10.1002/hup.2308
- By:
- Publication type:
- Article
Olanzapine and food craving: a case control study.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 97, doi. 10.1002/hup.2278
- By:
- Publication type:
- Article
Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 4, p. 386, doi. 10.1002/hup.2238
- By:
- Publication type:
- Article
Effects of Psychoeducation on Treatment Satisfaction in Schizophrenic Patients on Olanzapine Long Acting Injection.
- Published in:
- Archives of Psychiatry Research, 2022, v. 58, n. 1, p. 43, doi. 10.20471/may.2022.58.01.05
- By:
- Publication type:
- Article
D<sub>2</sub> Receptor Occupancy of Olanzapine Pamoate Depot Using Positron Emission Tomography: An Open-label Study in Patients with Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 2, p. 298, doi. 10.1038/sj.npp.1301409
- By:
- Publication type:
- Article